CONTACT US

 

INVESTORS

For investor inquiries, please contact:
Ms. Melodee Newbold
Assoc VP, Investor Relations at (909) 307-9300 or Melodee.Newbold@genelux.com

 

MEDIA

For media inquiries please call:
Tiberend Strategic Advisors
Miriam Weber Miller at (212) 375-2694 or mmiller@tiberend.com

 

PATIENTS

Genelux Corporation does not recruit or select patients for clinical trials. Information about selection can be obtained from participating clinical partners or on the web at www.clinicaltrials.gov

 

GENERAL INFORMATION

For general information, please contact: